Get started

Press Releases

Delayed 3m

Fastest customizable press release feed in the world.

Signed out · 3-min delay · Sign up for real-time

Updates arrive automatically.

  • UFP Technologies Announces Strong Q3 Results
    PR·

    UFP Technologies Announces Strong Q3 Results

    UFP Technologies, Inc. (NASDAQ:UFPT), a trusted contract development and manufacturing organization specializing in comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today reported net income of $20.6 million for its third quarter ended September 30, 2026, 25.8% higher than net income of $16.4 million for the third quarter of 2025. Net sales for the quarter ended September 30, 2026 were $172.4 million, 11.6% higher than 2025 third quarter sales of $154.6 million. Generally accepted accounting principles ("GAAP") and adjusted earnings per diluted common share outstanding ("EPS") for the quarter ended September 30, 2026 were $2.64 and

    $UFPT
  • Telos Corporation Awarded Xacta Contract by U.S. Department of State
    PR·

    Telos Corporation Awarded Xacta Contract by U.S. Department of State

    Telos Corporation (NASDAQ:TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced a new contract award from the U.S. Department of State for Xacta 360™ subscriptions and cybersecurity services. Under the 12-month award, Telos will provide a customer-hosted, customer-managed Xacta 360 subscription, along with technical expertise and cyber compliance assessment services. Xacta 360 will support the department’s security authorization, control assessment, compliance documentation and continuous monitoring activities. "Federal agencies need a clear, current

    $TLS
  • Caesarstone Reschedules Third Quarter 2026 Results and Conference Call to November 11, 2026
    PR·

    Caesarstone Reschedules Third Quarter 2026 Results and Conference Call to November 11, 2026

    Caesarstone Ltd. (NASDAQ:CSTE), a leading developer and manufacturer of high-quality engineered surfaces, today announced that it has rescheduled the release of its earnings results for the third quarter ended September 30, 2026 to allow additional time for settlement discussions related to current legal proceedings. The Company now plans to release its results on Wednesday, November 11, 2026 before the market opens. The release was previously scheduled for Wednesday, November 4, 2026. The Company will host a webcast and conference call on the same day at 8:30 a.m. ET to discuss the results. The live webcast can be accessed through the Investor Relations section of the Company’s website a

    $CSTE
  • First Industrial Declares Common Stock Dividends
    PR·

    First Industrial Declares Common Stock Dividends

    First Industrial Realty Trust, Inc. (NYSE:FR), a leading fully integrated owner, operator and developer of logistics real estate, today announced that its board of directors declared a common stock dividend of $0.50 per share/unit for the quarter ending December 31, 2026 payable on January 19, 2027 to stockholders of record on December 31, 2026. About First Industrial Realty Trust, Inc. First Industrial Realty Trust, Inc. (NYSE:FR) is a leading U.S.-only owner, operator, developer and acquirer of logistics properties. Through our fully integrated operating and investing platform, we provide

    $FR
  • Innospec REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
    PR·

    Innospec REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS

    All businesses contributed to revenue and operating income growth Continued strength in Fuel Specialties; Double-digit operating income growth in Performance Chemicals and Oilfield Services Cash flow of $17.4 million generated from operations; Net cash improved to $251.9 million GAAP EPS $1.29 and adjusted non-GAAP EPS $1.29 Semi-annual dividend of 94 cents; Annual dividend increased by 9 percent

    $IOSP
  • Concentrix Announces Chief Financial Officer Succession
    PR·

    Concentrix Announces Chief Financial Officer Succession

    Concentrix Corporation (NASDAQ:CNXC), a global technology and services leader, announced today that the company has selected Chinnu S. Varghese to become its Chief Financial Officer, effective December 1, 2026. Varghese will succeed Andre Valentine, the company’s current CFO, who will continue with the business through May 31, 2027 to ensure a smooth transition process before closing out a nearly 30-year career with Concentrix. "With a proven track record in world-class finance organizations, Chinnu blends financial and operational rigor with a strong understanding of clients and how to navigate change. That experience positions us well to

    $CNXC
  • Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    PR·

    Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Autolus Therapeutics plc (NASDAQ:AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced that the Compensation Committee of the Company's Board of Directors granted stock option awards to purchase an aggregate of 75,400 American Depositary Shares and 129,310 restricted stock units (RSUs), each representing an equal number of ordinary shares, to 15 employees pursuant to the Company’s 2025 Inducement Plan. The stock options and RSUs were granted as an inducement material to the individual becoming an employee of Autol

    $AUTL
  • MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares
    PR·

    MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares

    MediWound Announces $15 Million Bought Deal Offering of Ordinary Shares YAVNE, Israel, November 3, 2026 (GLOBE NEWSWIRE) — MediWound Ltd. (NASDAQ:MDWD) ("MediWound"), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 1,200,000 ordinary shares of MediWound, at a price to the public of $12.50 per ordinary share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about November 5, 2026, subject to satisfaction of customary closing conditions. H

    $MDWD
  • Kadant Reports Third Quarter 2026 Results
    PR·

    Kadant Reports Third Quarter 2026 Results

    Kadant Inc. (NYSE:KAI) reported its financial results for the third quarter ended October 3, 2026. Third Quarter Financial Highlights Bookings increased 22% to $291 millionRevenue increased 15% to a record $313 millionGross margin decreased 50 basis points to 44.7%Net income increased 27% to $35 millionGAAP EPS increased 26% to $2.96 Adjusted EPS increased 21% to a record $3.64Adjusted EBITDA increased 24% to a record $72 million and represented 22.9% of revenueOperating cash flow increased 33% to a record $63 million Note: Percent changes above are based on comparison to the corresponding prior year quarter. All references to earnings

    $KAI
  • JELD-WEN Reports Third Quarter 2026 Results
    PR·

    JELD-WEN Reports Third Quarter 2026 Results

    JELD-WEN Holding, Inc. (NYSE:JELD) ("JELD-WEN" or the "Company") today announced results for the three and nine months ended September 26, 2026. Comparability is to the same period in the prior year. Third Quarter 2026 HighlightsNet revenues of $798.5 million decreased (1.4%) in the third quarter driven by a decrease in Core Revenues of (1%). The decline in Core Revenues was driven by a (2%) decrease in volume/mix, partially offset by a 1% benefit from price realization. Net loss was ($17.2) million or ($0.20) per share, compared to net loss of ($367.6) million, or ($4.30) per share,

    $JELD
  • Bristow Group Reports Third Quarter 2026 Results
    PR·

    Bristow Group Reports Third Quarter 2026 Results

    Third Quarter HighlightsTotal revenues of $437.9 million in Q3 2026 compared to $411.8 million in Q2 2026Net income of $27.7 million, or $0.93 per diluted share, in Q3 2026 compared to net income of $21.2 million, or $0.70 per diluted share, in Q2 2026Adjusted EBITDA(1) in Q3 2026 was $89.6 million compared to $79.8 million in Q2 2026Repurchased 547,785 shares for total consideration of $25.0 million. Declared a quarterly cash dividend of $0.125 per share of common stockAffirms 2026

    $VTOL
  • SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2026 RESULTS
    PR·

    SUMMIT HOTEL PROPERTIES REPORTS THIRD QUARTER 2026 RESULTS

    Third Quarter Operating Income Increased 90.3% to $16.3 Million; Adjusted EBITDAre Increased 11.8% to $43.9 MillionThird Quarter Pro Forma RevPAR Increased 7.2%, Driving a 14.4%

    $INN
  • WhiteFiber Completes Acquisition of Two North Carolina Data Center Development Sites and Provides NC-1 Update
    PR·

    WhiteFiber Completes Acquisition of Two North Carolina Data Center Development Sites and Provides NC-1 Update

    WhiteFiber, Inc. (NASDAQ:WYFI) ("WhiteFiber" or the "Company"), a provider of artificial intelligence infrastructure solutions, today announced that, through its wholly owned subsidiary Enovum Data Centers Corp., it has completed the previously announced acquisition of two industrial properties in Yadkin County, North Carolina, designated NC-2 and NC-3. The purchase price for the properties was $60 million, paid in cash. Located approximately 55 miles from WhiteFiber's NC-1 campus in Madison, North Carolina, the properties comprise approximately 120 acres of land and 500,000 square feet of

    $WYFI
  • Vanda Pharmaceuticals Announces Participation at November 2026 Investor Conferences
    PR·

    Vanda Pharmaceuticals Announces Participation at November 2026 Investor Conferences

    Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA) today announced that the company will participate at the following upcoming investor conferences in November 2026: The 8th Annual Wolfe Research Healthcare Conference in New York City on Tuesday, November 10, 2026. The Stifel 2026 Healthcare Conference in New York City on Wednesday, November 11, 2026. A fireside chat is scheduled for 8:40 a.m. Eastern Time. The Truist Securities 2026 Biopharma Symposium in New York City on Thursday, November 12, 2026. The UBS Global Biopharma Conference in London on Tuesday, November 17, 2026. The Jefferies Gl

    $VNDA
  • Viking Therapeutics to Participate at Upcoming Investor Conferences
    PR·

    Viking Therapeutics to Participate at Upcoming Investor Conferences

    Viking Therapeutics, Inc. ("Viking") (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that it will participate at the Stifel 2026 Healthcare Conference, Truist 2026 BioPharma Symposium, UBS Global Biopharma Conference, Jefferies Global Healthcare Conference, and the Piper Sandler 38th Annual Healthcare Conference in November and December. Details of the company's participation are as follows:Stifel 2026 Healthcare ConferenceDetails: Viking management will participate in a fireside

    $VKTX
  • Solstice Advanced Materials Declares Dividend of $0.075 per Common Share
    PR·

    Solstice Advanced Materials Declares Dividend of $0.075 per Common Share

    Solstice Advanced Materials (NASDAQ:SOLS), today announced that its Board of Directors has declared a regular quarterly dividend payment of seven and a half cents ($0.075) per share of the Company's common stock. The dividend will be payable on December 10, 2026, to shareowners of record as of the close of business on November 25, 2026. About Solstice Advanced Materials Solstice Advanced Materials is a leading global specialty materials company that advances science for smarter outcomes. Solstice offers high-performance solutions that enable critical industries and applications,

    $SOLSV$SOLS
  • Verra Mobility Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
    PR·

    Verra Mobility Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

    Verra Mobility Corporation (NASDAQ:VRRM) (the "Company"), a leading provider of smart mobility technology solutions, announced today that it granted an inducement award to Jon Newhard on November 2, 2026, in connection with Mr. Newhard's appointment as President and Chief Executive Officer of the Company, effective November 1, 2026 (the "CEO Commencement Date"), pursuant to the employment agreement entered into between the Company and Mr. Newhard on October 1, 2026. The award was granted as an inducement material to Mr. Newhard's employment with the Company and was approved by the Company's Compensation Committee, in accordance with Nasdaq Listing R

    $VRRM
  • Dauch Corporation Announces Employee Inducement Award Under NYSE Rule 303A.08
    PR·

    Dauch Corporation Announces Employee Inducement Award Under NYSE Rule 303A.08

    Dauch Corporation ("Dauch"), (NYSE:DCH, LSE: DCH)) today announced effective November 2, 2026, in connection with his appointment as Senior Vice President of Finance of Dauch, Nathan Iles was granted the following equity awards (collectively, the "Inducement Grant"): (i) an award of performance stock units covering a target of 90,909 shares of Dauch's common stock (for which up to 272,727 shares may be earned) (the "Performance Breakout Award"), and (ii) an award of time-based restricted stock units covering 107,759 shares of Dauch's common stock, which will vest upon the first anniversary of the grant date, subject to his continued employment with Dauch

    $DCH
  • Tronox Declares Fourth Quarter 2026 Dividend
    PR·

    Tronox Declares Fourth Quarter 2026 Dividend

    Tronox Holdings plc (NYSE:TROX), the world's leading integrated manufacturer of titanium dioxide pigment, announced today that its Board of Directors declared a quarterly dividend of $0.05 per share. The dividend is payable on January 15, 2027 to shareholders of record at the close of business on November 16, 2026. About TronoxTronox Holdings plc is one of the world's leading producers of high-quality titanium products, including titanium dioxide pigment, specialty-grade titanium dioxide products and high-purity titanium chemicals, and zircon. We mine titanium-bearing mineral sands

    $TROX
  • Hormel Foods Corporation Announces Fourth Quarter Earnings Call
    PR·

    Hormel Foods Corporation Announces Fourth Quarter Earnings Call

    Hormel Foods Corporation (NYSE:HRL), a Fortune 500 global branded food company, invites interested parties to participate in a webcast and conference call with John Ghingo, president and chief executive officer, and Ash Bhumbla, executive vice president and chief financial officer, to discuss the Company's fourth-quarter and full-year financial results, and provide commentary related to its fiscal 2027 outlook. The Company will issue its earnings release before the markets open on Thursday, Dec. 3, 2026, and will host a conference call at 8 a.m. CT (9 a.m. ET). The webcast, replay, an

    $HRL